Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 24,932 | 17,777 | 23,025 | 12,811 | 11,196 |
| Operating Income | -24,932 | -17,777 | -23,025 | -12,811 | -11,196 |
| Interest Expense | N/A | 0 | 515 | N/A | N/A |
| Other Income | 926 | -4,605 | 2,817 | 85 | 10 |
| Pre-tax Income | -24,006 | -22,382 | -20,722 | -12,727 | -11,186 |
| Net Income Continuous | -24,006 | -22,382 | -20,722 | -12,727 | -11,186 |
| Net Income | $-24,006 | $-22,382 | $-20,722 | $-12,727 | $-11,186 |
| EPS Basic Total Ops | -0.36 | -0.38 | -0.39 | -0.32 | -0.35 |
| EPS Basic Continuous Ops | -0.36 | -0.38 | -0.39 | -0.32 | -0.35 |
| EPS Diluted Total Ops | -0.36 | -0.38 | -0.39 | -0.32 | -0.35 |
| EPS Diluted Continuous Ops | -0.36 | -0.38 | -0.39 | -0.32 | -0.35 |
| EBITDA(a) | $-24,848 | $-22,237 | $-20,093 | $-12,769 | $-11,156 |